27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
As data are quickly becoming significant corporate assets, it’s important to help companies both ma...
Read More >
A new California law, stemming from Assembly Bill 5 (AB 5), expands and codifies the California Supr...
Read More >
As we turn our attention to 2021, here at Hogan Lovells we are buoyed by prospects of a steadier eco...
Read More >
Trampoline park injuries are sending thousands of kids to hospital emergency rooms each year and Chi...
Read More >
I once had a law school professor who joked that we change the bankruptcy laws to give business to b...
Read More >
The National Labor Relations Board (NLRB or the “Board”) has been steadily increasing employers’ ...
Read More >